Legal & General Group
TPST icon

Legal & General Group’s Tempest Therapeutics TPST Stock Holding History

Legal & General Group’s Portfolio TPST Stock Details TPST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-9
Closed -$10K – 3464
2020
Q1 		$10K Sell
9
-1
-10% -$1.46K ﹤0.01% 3162
2019
Q4 		$13K Buy
10
+2
+25% +$2.82K ﹤0.01% 3262
2019
Q3 		$11K Hold
8
– – ﹤0.01% 3257
2019
Q2 		$18K Buy
+8
New +$23.5K ﹤0.01% 3244
2017
Q3 		– Sell
-157
Closed -$713K – 3321
2017
Q2 		$713K Buy
157
+154
+5,133% +$652K ﹤0.01% 1948
2017
Q1 		$19K Buy
3
+1
+50% +$4.66K ﹤0.01% 3091
2016
Q4 		$10K Hold
2
– – ﹤0.01% 3211
2016
Q3 		$32K Hold
2
– – ﹤0.01% 2716
2016
Q2 		$24K Buy
2
+1
+100% +$22.8K ﹤0.01% 2809
2016
Q1 		$23K Hold
1
– – ﹤0.01% 2650
2015
Q4 		$24K Hold
1
– – ﹤0.01% 2675
2015
Q3 		$20K Hold
1
– – ﹤0.01% 2710
2015
Q2 		$72K Hold
1
– – ﹤0.01% 2355
2015
Q1 		$94K Hold
1
– – ﹤0.01% 2084
2014
Q4 		$117K Buy
+1
New +$73.2K ﹤0.01% 1861

Other funds holding TPST

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
B
Bpifrance Maisons Alfort, Cedex, France $1.65B AUM 19.85% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Legal & General Group's TPST Position: Q2 2020 in Review

Legal & General Group sold out of Tempest Therapeutics (TPST) in Q2 2020, closing a stake of 9 shares — an estimated $10K sold.

Legal & General Group first reported a position in TPST in Q4 2014 and held it in 15 quarters. The position peaked at $713K in Q2 2017. 51 funds tracked by Wall St. Rank hold TPST as of Q2 2020.

  • Legal & General Group reported no remaining Tempest Therapeutics position as of Q2 2020 after selling out during the quarter.
  • Legal & General Group sold 9 Tempest Therapeutics shares in Q2 2020, an estimated $10K.
  • Legal & General Group first reported a position in Tempest Therapeutics in Q4 2014 and held it in 15 quarters.
  • Legal & General Group's Tempest Therapeutics position peaked at $713K in Q2 2017.
  • 51 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q2 2020.

Based on Legal & General Group's 13F filing for Q2 2020, filed 14 Aug 2020.